Compare SRZN & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRZN | ZH |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | China |
| Employees | 44 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.3M | 295.1M |
| IPO Year | N/A | 2021 |
| Metric | SRZN | ZH |
|---|---|---|
| Price | $21.50 | $3.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | 77.8K | ★ 170.0K |
| Earning Date | 05-08-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.00 | $2.57 |
| 52 Week High | $35.00 | $5.55 |
| Indicator | SRZN | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 34.64 | 49.77 |
| Support Level | $20.02 | $3.09 |
| Resistance Level | $24.50 | $3.51 |
| Average True Range (ATR) | 1.94 | 0.12 |
| MACD | -0.49 | 0.02 |
| Stochastic Oscillator | 17.44 | 62.35 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.